ATE157867T1 - Geschmacksmaskierende zusammensetzungen von ranitidin - Google Patents

Geschmacksmaskierende zusammensetzungen von ranitidin

Info

Publication number
ATE157867T1
ATE157867T1 AT93923462T AT93923462T ATE157867T1 AT E157867 T1 ATE157867 T1 AT E157867T1 AT 93923462 T AT93923462 T AT 93923462T AT 93923462 T AT93923462 T AT 93923462T AT E157867 T1 ATE157867 T1 AT E157867T1
Authority
AT
Austria
Prior art keywords
ranitidine
pct
date apr
flavor
lipid
Prior art date
Application number
AT93923462T
Other languages
English (en)
Inventor
Stephen John Douglas
Jill Evans
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929221760A external-priority patent/GB9221760D0/en
Priority claimed from GB929221800A external-priority patent/GB9221800D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE157867T1 publication Critical patent/ATE157867T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
AT93923462T 1992-10-16 1993-10-14 Geschmacksmaskierende zusammensetzungen von ranitidin ATE157867T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929221760A GB9221760D0 (en) 1992-10-16 1992-10-16 Medicaments
GB929221800A GB9221800D0 (en) 1992-10-16 1992-10-16 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE157867T1 true ATE157867T1 (de) 1997-09-15

Family

ID=26301808

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93923462T ATE157867T1 (de) 1992-10-16 1993-10-14 Geschmacksmaskierende zusammensetzungen von ranitidin

Country Status (12)

Country Link
US (1) US5635200A (de)
EP (1) EP0664701B1 (de)
JP (1) JPH08510989A (de)
CN (1) CN1052877C (de)
AT (1) ATE157867T1 (de)
AU (1) AU669952B2 (de)
CA (1) CA2146999A1 (de)
DE (1) DE69313865T2 (de)
ES (1) ES2107685T3 (de)
IL (1) IL107303A (de)
MX (1) MX9306393A (de)
WO (1) WO1994008576A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000125A1 (en) * 1993-06-18 1995-01-05 Smithkline Beecham Corporation Soft-shelled gelatin encapsulated particles
MY111346A (en) * 1993-07-09 1999-11-30 Smithkline Beecham Corp Soft-shelled gelatin encapsulated particles
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
DK171127B1 (da) * 1994-04-22 1996-06-24 Gea Farmaceutisk Fabrik As Ranitidintablet med et hydroxypropylmethylcelluloseholdigt overtræk samt fremgangsmåde til at tilvejebringe dette overtræk
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
BR9608962A (pt) 1995-06-09 1999-06-29 R P Scheer Corp Suspensão de um agente ativo apropriado e cápsula de gelatina
US5706830A (en) * 1996-05-06 1998-01-13 South Alabama Medical Science Foundation Liquid ventilator system and use thereof
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
WO1998014179A1 (en) * 1996-10-01 1998-04-09 Cima Labs Inc. Taste-masked microcapsule compositions and methods of manufacture
US6242019B1 (en) 1997-08-14 2001-06-05 Warner-Lambert Company Taste modified hard confectionery compositions containing functional ingredients
NZ503086A (en) 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
GB9806477D0 (en) * 1998-03-26 1998-05-27 Glaxo Group Ltd Improved crystals
GB9819272D0 (en) * 1998-09-03 1998-10-28 Andaris Ltd Microparticles
JP2002179560A (ja) * 1999-02-26 2002-06-26 Shionogi & Co Ltd 服用性を改良した咀嚼型ソフトカプセル剤およびその製法
EP1163901B1 (de) 1999-02-26 2008-09-10 Shionogi & Co., Ltd. Kaubare weichkapseln mit verbesserten verabreichungseigenschaften sowie verfahren zu deren herstellung
PT1165042E (pt) 1999-04-06 2005-06-30 Ethypharm Sa Suspensao farmaceutica bebivel de ibuprofeno
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
AU2003209673B2 (en) * 2002-03-08 2007-10-18 M/S. Ind-Swift Limited Tasteless directly compressible fast-dissolving complexes and pharmaceutical formulations thereof
US20040096498A1 (en) * 2002-04-29 2004-05-20 Alvin Kershman Oral pharmaceutical delivery system with improved sustained release
WO2004016247A1 (en) * 2002-08-14 2004-02-26 E.I. Du Pont De Nemours And Company Process for coating a pharmaceutical particle
FR2848855B1 (fr) * 2002-12-23 2005-02-11 Aventis Pharma Sa Compositions pour administration orale de principes actifs necessitant un masquage du gout
US20040146553A1 (en) 2002-12-23 2004-07-29 Aventis Pharma S.A. Compositions for oral administration of active principles requiring masking of taste
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20040185170A1 (en) * 2003-03-21 2004-09-23 Shubha Chungi Method for coating drug-containing particles and formulations and dosage units formed therefrom
WO2004091582A1 (en) * 2003-04-17 2004-10-28 Ipca Laboratories Limited Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them
US8545881B2 (en) 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture
ITMI20041820A1 (it) * 2004-09-24 2004-12-24 Ascor Chimici Srl Composizione in micro-pellets a rilascio controllato di sostanze fisiologicamente attive, procedimento di preparazione e relativo impiego nel settore zootecnico.
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
WO2006047493A2 (en) 2004-10-21 2006-05-04 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
JP5609105B2 (ja) * 2009-12-24 2014-10-22 ライオン株式会社 ラニチジン含有被覆粒子及びその製造方法
FR2959130A1 (fr) * 2010-04-21 2011-10-28 Sanofi Aventis Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant.
US20160000714A1 (en) 2013-03-06 2016-01-07 Capsugel Belgium Nv Curcumin solid lipid particles and methods for their preparation and use
EP3154529B1 (de) * 2014-06-10 2020-07-08 Capsugel Belgium NV Orale, schnell-zerfallende tablette mit festen lipidpartikeln und verfahren zu deren herstellung und verwendung
WO2016087261A1 (en) 2014-12-04 2016-06-09 Capsugel Belgium N.V. Lipid multiparticulate formulations
CN105030694A (zh) * 2015-08-04 2015-11-11 青岛蓝盛洋医药生物科技有限责任公司 一种治疗胃溃疡的药物盐酸雷尼替丁组合物干混悬剂
CN112020350A (zh) 2018-04-27 2020-12-01 强生消费者公司 液体口服药物剂型
US20240226038A9 (en) * 2022-10-19 2024-07-11 Genexa Inc. Solid pharmaceutical tablet
WO2025253307A1 (en) * 2024-06-04 2025-12-11 Kenvue Brands Llc Softgel capsule comprising a h2 receptor antagonist

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE74009T1 (de) * 1986-08-11 1992-04-15 American Cyanamid Co Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
US5219563A (en) * 1988-05-11 1993-06-15 Glaxo Group Limited Drug adsorbates
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
US5275823A (en) * 1989-04-27 1994-01-04 Smith Kline & French Laboratories Ltd. Pharmaceutical compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
EP0421581A1 (de) * 1989-10-03 1991-04-10 Warner-Lambert Company Kaubare sprühgetrocknete spheroide Mikrokapseln, wachsüberzogene Mikrokapseln und Verfahren zu ihrer Herstellung
US5290569A (en) * 1990-04-12 1994-03-01 Shionogi & Co., Ltd. Coated composition and its preparation process
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
WO1992004893A1 (en) * 1990-09-13 1992-04-02 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
FI922107A0 (fi) * 1991-05-10 1992-05-08 Faulding F H & Co Ltd Mikrokapselkomposition och foerfarande.
ES2202302T3 (es) * 1991-05-28 2004-04-01 Mcneil-Ppc, Inc. Composicion masticable que libera un farmaco.
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
US5429825A (en) * 1992-06-26 1995-07-04 Mcneil-Ppc, Inc. Rotomelt granulation

Also Published As

Publication number Publication date
CN1052877C (zh) 2000-05-31
DE69313865T2 (de) 1998-02-12
DE69313865D1 (de) 1997-10-16
AU5333694A (en) 1994-05-09
IL107303A0 (en) 1994-01-25
JPH08510989A (ja) 1996-11-19
MX9306393A (es) 1994-04-29
EP0664701A1 (de) 1995-08-02
CN1092648A (zh) 1994-09-28
ES2107685T3 (es) 1997-12-01
US5635200A (en) 1997-06-03
WO1994008576A1 (en) 1994-04-28
IL107303A (en) 1998-02-08
EP0664701B1 (de) 1997-09-10
CA2146999A1 (en) 1994-04-28
AU669952B2 (en) 1996-06-27

Similar Documents

Publication Publication Date Title
DE69313865D1 (de) Geschmacksmaskierende zusammensetzungen von ranitidin
GB1527605A (en) Insulin preparation for intranasal administration
NO20022264D0 (no) Farmasöytisk blanding inneholdende tolterodin, samt anvendelse derav
DE69105106D1 (de) Im wasser schnell suspendierbare pharmazeutische zusammensetzung.
IL109448A0 (en) Risperidone pamoate, its preparation and pharmaceutical compositions containing it
FI945912A0 (fi) Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö
IL108520A0 (en) Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
BR0107749A (pt) Métodos de uso de uma composição de bebida
RU94041210A (ru) [/бензодиоксан, бензофуран или бензопиран/-алкиламино]-алкилзамещенные гуанидины в качестве селективных сосудосуживающих средств, способ их получения, промежуточное для них, композиция и способ ее получения
BR9807076B1 (pt) "uso de acetato de glatirâmero para a fabricação de medicamento para o tratamento de esclerose múltipla e composição farmacêutica"
YU2494A (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
GB2334446B (en) Aqueous compositions compromising a lipid and a lanolin-derived surfactant,and their use
GR3036966T3 (en) Stabilized pseudo-emulsions and their preparation process
NO972623D0 (no) Framasöytisk blanding omfattende lamotrigin
YU28002A (sh) Farmaceutska kompozicija koja sadrži ciklesonid za primenu na sluzokoži
CZ125895A3 (en) The use of dimethylbenzofuran and dimethylbenzopyran derivatives as 5-ht3antagonists, novel dimethylbenzofuran and dimethylbenzopyran derivatives, intermediates for preparing thereof and pharmaceutical preparations
ATE246515T1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
ES2186207T3 (es) Metodo para preparacion de formulaciones farmaceuticas.
BG103739A (en) Aqueous pharmaceutical composition containing hard soluble active substance in water
KR950016718A (ko) 이부프로펜 함유 고형 조성물
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
CA2331284A1 (en) Solution comprising prostaglandins and benzyl alcohol
HRP930833B1 (en) Water soluble retinoids
GB9806172D0 (en) Process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent(s) and micro organisms as active ingredients

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties